Table:
begin	end	state
1	8	cytoplasmic
9	30	transmembrane
31	49	non-cytoplasmic
50	69	transmembrane
70	79	cytoplasmic
80	103	transmembrane
104	106	non-cytoplasmic
107	127	transmembrane
128	138	cytoplasmic
139	160	transmembrane
161	184	non-cytoplasmic
185	204	transmembrane
205	262	cytoplasmic
263	285	transmembrane
286	299	non-cytoplasmic
300	322	transmembrane
323	328	cytoplasmic
329	352	transmembrane
353	357	non-cytoplasmic
358	381	transmembrane
382	391	cytoplasmic
392	413	transmembrane
414	419	non-cytoplasmic
420	439	transmembrane
440	460	cytoplasmic

Input:
>WP_010536987.1 NCBI__GCF_000226135.1:WP_010536987.1
MKSYNKKFVYSICLVSAMGGLLFGYDWVVIGGAKPFYELYFDIADSPTMQGLAMSVALLG
CLIGAMVAGMMADRYGRKPLLLISAFIFLSSAYATGAFSVFSWFLVARFLGGIGIGIASG
LSPMYIAEVAPTSIRGKLVSLNQLTIVLGILGAQIANWLIAEPIPADFTPADICASWNGQ
MGWRWMFWGAAFPAAVFLLLACFIPESPRWLAMKGKRERAWNVLSKIGGNHYAEQELQMV
EQTGSSKSEGGLKLLFSRPFRKVLVLGIIVAVFQQWCGTNVIFNYAQEIFQSAGYSLGDV
LFNIVVTGVANVIFTFVAIYTVERLGRRVLMLLGAGGLAGIYLVLGTCYFFQVSGFFMVV
LVVLAIACYAMSLGPITWVLLAEIFPNRVRGVAMATCTFALWVGSFTLTYTFPLLNSALG
SYGTFWIYSAICLVGFVFFRRALPETKGKSLETLEKDLIK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server